Umicore Argentina plant, which produces a series of anti-cancer active pharmaceutical ingredients, was successfully audited for the second time by the US Food and Drug Administration (FDA) in May 2018.
Umicore's business unit Precious Metals Chemistry, is proud to announce that it is expanding its existing cross coupling catalyst portfolio with Buchwald precatalysts after it licensed this technology from the Massachusetts Institute of Technology…
Umicore’s Active Pharmaceutical Ingredients facility in Pilar, Buenos Aires, successfully passed its second cGMP (current Good Manufacturing Practice) audit by the US Food and Drug Administration (FDA) in May 2018. The Auditor acknowledged that…
Umicore announced today that it has reached an agreement to acquire Materia's metathesis catalyst business for an enterprise value of USD million 27. Materia is a leader in metathesis with its unique proprietary technology developed by 2005…
We are proud to announce the successfully audit of Umicore’s facility in Hanau (Germany) by the
Together for Sustainability (TfS) initiative. This confirms and reinforces Umicore’s policy and commitment to sustainability.
Umicore’s business unit Precious Metals Chemistry inaugurated today its innovative production unit for advanced metal organic precursor technologies used in the semiconductor and LED markets, respectively TMGa (Trimethylgallium) and TEGa…
Umicore’s API (Active Pharmaceutical Ingredients) facility in Pilar, Buenos Aires, successfully underwent a European GMP (Good Manufacturing Practice) inspection by the German Health and Medicine Authority. The success of this new audit confirms…
We are proud to announce the successful Go-Live of Umicore's new brand image and Precious Metals Chemistry's renewed website. Our customers and partners now benefit from even more online technical product and service information. Please contact us…
Umicore uses certain monitoring and tracking technologies such as cookies. These technologies are used in order to maintain, provide and improve our services on an ongoing basis, and in order to provide our web visitors with a better experience.
By clicking on the "Accept all" button you agree to the use of these cookies while using the website. For further information regarding how we use cookies and other tracking technologies, please see section 11 of our website privacy notice.
